Top

International Ophthalmology

Published in:

01-05-2020 | Original Paper

Protective effects of autophagy inhibitor 3-methyladenine on ischemia–reperfusion-induced retinal injury

Authors: Xiaorui Wang, Yuyu Wu

Published in: International Ophthalmology | Issue 5/2020

Abstract

Objective

To investigate the protective effects of autophagy inhibitor 3-methyladenine (3-MA) in a rat model of ischemic–reperfusion injury (IRI).

Methods

Forty Sprague–Dawley male rats (weight 220–250 g) were randomly divided into four groups: a control group (NC, n = 10), a Sham surgery group (n = 10), an IRI group (n = 10), and a 3-MA-treated IRI group [10 μL 3-MA (10 mmol/L) was injected in vitreous after the injury, n = 10]. The retinal IRI was induced by elevating the intraocular pressure to 110 mmHg for 60 min. Hematoxylin and eosin (HE) staining was used to calculate the number of retinal ganglion cells (RGCs). The level of microtubule-associated protein 1A/1B light chain 3 (LC3), Beclin-1, and Caspase-3 in the retina was detected using the immunofluorescence staining method. The LC3, Beclin-1, B-cell lymphoma/leukemia-2 (Bcl-2), and Caspase-3 protein levels were examined by Western blotting.

Results

The number of RGCs in IRI group was significantly lower than that in NC group (P < 0.05), demonstrated by HE staining. Western blotting results indicated that the protein expression of LC3 and Beclin-1 in the IRI group was significantly elevated compared with those in the NC group (P < 0.05). However, with 3-MA treatment, the number of RCGs in 3-MA-treated IRI group was elevated and protein levels of LC3, Beclin-1 were down-regulated, compared with those in the IRI group (P < 0.05). Further immunohistochemistry staining and Western blot showed that 3-MA-treated IRI group presented down-regulated Caspase-3 and up-regulated Bcl-2 protein expression with comparison of IRI group (P < 0.05).

Conclusions

Retina IRI-caused RGCs loss involved activated autophagy pathway and apoptosis, which could be prevented by autophagy inhibitor 3-MA. Autophagy inhibitor 3-MA may act as a potent therapeutic tool in attenuating retina IRI.

Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW (2013) Ischaemia–reperfusion injury in liver transplantation—from bench to bedside. Nat Rev Gastroenterol Hepatol 10(2):79–89PubMedCrossRef

Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23(1):91–147PubMedCrossRef

Wei T, Kang Q, Ma B, Gao S, Li X, Liu Y (2015) Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats. Exp Ther Med 9(2):476–482PubMedCrossRef

Ko ML, Chen CF, Peng PH, Peng YH (2011) Simvastatin up-regulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina. Exp Eye Res 93(5):580–585PubMedCrossRef

McKnight NC, Zhenyu Y (2013) Beclin 1, an essential component and master regulator of PI3K-III in health and disease. Curr Pathobiol Rep 1(4):231–238PubMedPubMedCentralCrossRef

Fan TJ, Han LH, Cong RS, Liang J (2005) Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 37(11):719–727CrossRef

Kabeya Y, Mizushima N, Ueno T et al (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19(21):5720–5728PubMedPubMedCentralCrossRef

Oberstein A, Jeffrey PD, Shi Y (2007) Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282(17):13123–13132PubMedCrossRef

Marquez RT, Xu L (2012) Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res. 2(2):214–221PubMedPubMedCentral

10.

Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 79(6):1889–1892PubMedCrossRefPubMedCentral

11.

Lee YR, Wang PS, Wang JR, Liu HS (2014) Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model. J Biomed Sci 21:80PubMedPubMedCentralCrossRef

12.

Dai S, Wang B, Li W et al (2016) Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE(−/−) mice by modulating autophagy, foam cell formation and immune-negative molecules. Cell Death Dis 7(12):e2498PubMedPubMedCentralCrossRef

13.

Zhou HH, Wu DL, Gao LY, Fang Y, Ge WH (2016) l-Tetrahydropalmatine alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. NeuroReport 27(7):476–480PubMedCrossRef

14.

Ito S, Koshikawa N, Mochizuki S, Takenaga K (2007) 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol 31(2):261–268PubMed

15.

Piras A, Gianetto D, Conte D, Bosone A, Vercelli A (2011) Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure. PLoS ONE 6(7):e22514PubMedPubMedCentralCrossRef

16.

Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Diwan A (2012) Autophagy is impaired in cardiac ischemia–reperfusion injury. Autophagy 8(9):1394–1396PubMedPubMedCentralCrossRef

17.

Zhang YL, Zhang J, Cui LY, Yang S (2015) Autophagy activation attenuates renal ischemia–reperfusion injury in rats. Exp Biol Med (Maywood) 240(12):1590–1598CrossRef

18.

Zhang X, Yan H, Yuan Y et al (2013) Cerebral ischemia–reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 9(9):1321–1333PubMedCrossRef

19.

Chen G, Tang L, Wei W et al (2016) mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia. Sci Rep 6:37805PubMedPubMedCentralCrossRef

20.

Russo R, Varano GP, Adornetto A et al (2018) Rapamycin and fasting sustain autophagy response activated by ischemia/reperfusion injury and promote retinal ganglion cell survival. Cell Death Dis 9(10):981PubMedPubMedCentralCrossRef

21.

Ravikumar B, Sarkar S, Davies JE et al (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90(4):1383–1435PubMedCrossRef

22.

Maiuri MC, Criollo A, Tasdemir E et al (2007) BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3(4):374–376PubMedCrossRef

23.

Pattingre S, Tassa A, Qu X et al (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122(6):927–939PubMedCrossRef

24.

Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47–59PubMedCrossRef

25.

Antonsson B (2004) Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem 256–257(1–2):141–155PubMedCrossRef

26.

Baltadzhiev IG, Delchev SD (2013) Changes of Bcl-2, Bax and Caspase-3 expression in the dermal microvascular endothelial cells and the epidermal layers of the eschar (tache noire) in patients with Mediterranean spotted fever. Folia Histochem Cytobiol 51(2):121–126PubMedCrossRef

27.

Domart MC, Esposti DD, Sebagh M et al (2009) Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J Hepatol 51(5):881–889PubMedCrossRef

Title: Protective effects of autophagy inhibitor 3-methyladenine on ischemia–reperfusion-induced retinal injury
Authors: Xiaorui Wang
Yuyu Wu
Publication date: 01-05-2020
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 5/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-019-01272-9

At a glance: The STEP trials

Springer Medicine

Protective effects of autophagy inhibitor 3-methyladenine on ischemia–reperfusion-induced retinal injury

Abstract

Objective

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2020

Toric intraocular lens in asymmetric astigmatism

Comparison of the effects of 180° and 360° applications of selective laser trabeculoplasty on intraocular pressure and cornea

Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1%

Long non-coding RNA Arid2-IR affects advanced glycation end products-induced human retinal endothelial cell injury by binding to Smad3

Efficacy of the XEN gel stent on intraocular pressure lowering in East Asian eyes

Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients